I founded Diabetech, a company which pioneered mHealth in the field of diabetes in response to my younger daughter’s diagnosis with type 1 diabetes in May 2001 at the age of 27 months.
It was clear that there needed to be a way to facilitate remote monitoring of her condition but there were no tools available or in development yet. So, I designed a wireless medical device which attaches to industry standard blood glucose meters and automatically delivers ‘feedback loops’ to the right person, at the right time and in the right format. The device is called GlucoMON® and it connects over 3G cellular networks to the cloud-based Automated Diabetes Management System (ADMS). Together, GlucoMON-ADMS became a research platform which investigated many different uses for blood sugar data, mobile education and gaming to engage people in their own diabetes care. Clinical trials of GlucoMON-ADMS validated the efficacy of Diabetech’s simple, accurate and timely data collection technology including specific algorithms and feedback loops which encourage improved diabetes self-care.
As Diabetech’s CEO, in 2009 I licensed the technology to several health care and medical device companies looking to accelerate their path to market. The technologies developed by Diabetech are now distributed as embedded features of next generation cellular connected medical devices and cloud based back end systems here in the USA and the UK.